Patents by Inventor Daniel B. Davison

Daniel B. Davison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Essential fungal polypeptide, CaYDR341c, and methods of use thereof
    Patent number: 7790428
    Abstract: The present invention provides essential fungal polynucleotides and their encoded polypeptides, homologues thereof and their uses. Additionally, the invention provides methods for the identification of essential polynucleotides and fungal strains which may be used for drug screening.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: September 7, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ying-Kai Wang, Mengping Liu, Brian A. Dougherty, Matthew D. Healy, Daniel B. Davison, Charles E. Mazzucco, Trina Maurice
  • Essential fungal polynucleotides, polypeptides, and methods of use
    Patent number: 7465568
    Abstract: The presnt invention provides essential fungal polynucleotides and their encoded polypeptides, homologues thereof and their uses. Additionally, the invention provides methods for the identification of essential polynucleotides and fungal strains which may be used for drug screening.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: December 16, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ying-Kai Wang, Mengping Liu, Brian A. Dougherty, Matthew D. Healy, Daniel B. Davison, Charles E. Mazzucco, Trina C. Maurice
  • Essential fungal CaYLR100w polypeptides, and methods of use
    Patent number: 7442532
    Abstract: The present invention provides essential fungal polynucleotides and their encoded polypeptides, homologues thereof and their uses. Additionally, the invention provides methods for the identification of essential polynucleotides and fungal strains which may be used for drug screening.
    Type: Grant
    Filed: March 20, 2007
    Date of Patent: October 28, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ying-Kai Wang, Mengping Liu, Brian A. Dougherty, Matthew D. Healy, Daniel B. Davison, Charles E. Mazzucco, Trina Maurice
  • Polynucleotides encoding the human citron kinase polypeptide, BMSNKC0020/0021
    Patent number: 7326781
    Abstract: The present invention describes a novel human protein kinase related to citron kinase, and its encoding polynucleotide. Also described are expression vectors, host cells, antisense molecules, and antibodies associated with the protein kinase polynucleotide and/or polypeptide of this invention. In addition, methods for treating, diagnosing, preventing, and screening for disorders or diseases associated with abnormal biological activity of the protein kinase are described, as are methods for screening for modulators, e.g., agonists or antagonists, of the protein kinase activity and/or function.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: February 5, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Daniel B. Davison, John N. Feder, Liana M. Lee, Karl-Heinz Ott
  • Novel polynucleotides encoding the human citron kinase polypeptide, BMSNKC_0020/0021
    Publication number: 20030220224
    Abstract: The present invention describes a novel human protein kinase related to citron kinase, and its encoding polynucleotide. Also described are expression vectors, host cells, antisense molecules, and antibodies associated with the protein kinase polynucleotide and/or polypeptide of this invention. In addition, methods for treating, diagnosing, preventing, and screening for disorders or diseases associated with abnormal biological activity of the protein kinase are described, as are methods for screening for modulators, e.g., agonists or antagonists, of the protein kinase activity and/or function.
    Type: Application
    Filed: April 11, 2003
    Publication date: November 27, 2003
    Inventors: Daniel B. Davison, John N. Feder, Liana M. Lee, Karl-Heinz Ott